Real-World Effectiveness of SGLT2 Inhibitors vs. GLP-1 Receptor Agonists in Patients With and Without Cardiovascular Disease

Topics: 

Citation
Patorno E et al. Diabetes Jun 2019;68(Supplement 1):247-OR.